DENISE HAMILTON: Open Payments
NPI 1043657323 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,482 in 96 payments from 20 companies in 2025. Trend: 2023 $2,220 · 2024 $3,627 · 2025 $2,482
Food & beverage: $2,482
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $431 |
| ABBVIE INC. | 12 | $318 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $210 |
| GENZYME CORPORATION | 5 | $207 |
| Enterra Medical, Inc. | 1 | $173 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $161 |
| Ipsen Biopharmaceuticals, Inc | 6 | $158 |
| Madrigal Pharmaceuticals | 4 | $122 |
| PFIZER INC. | 5 | $119 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $115 |
Products named: TREMFYA, DUPIXENT, LINZESS, XIFAXAN, IQIRVO, ENTYVIO, REZDIFFRA, NEFFY.
Industry payments across VA — which companies pay providers there.
